Apr. 23 at 3:29 AM
$ATOS what is with the daily it’s bullish without backing it up with facts. Pure hopium. Makes zero sense why this company would be bullish. They are still in phase 2. Haven’t even begun second phase 2 which needs to be completed for even consideration with the FDA. where exactly is the hope. They are going to have to use every single shelf company in order to complete trials. How is this bullish??? Management get paid no matter what happens. They have been paid for a considerable amount of time and yet still in phase 2. In the time they have been developing endoxifen many cancer drugs have surpassed them.
